Rating History for Eloxx Pharma (ELOX) by Oppenheimer
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/2/2023 | Hartaj Singh | Maintain | Outperform (N/A) |
30.00 (60.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/2/2023 | Hartaj Singh | Maintain | Outperform (N/A) |
30.00 (60.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||